Thiadiazoline derivative

a technology of thiadiazoline and derivatives, applied in the field of anti-tumor agents, can solve the problems of side effects, bone marrow toxicity and neuropathy, and achieve the effects of reducing the number of side effects, neuropathy, and reducing the effect of toxicity

Inactive Publication Date: 2007-09-13
KYOWA HAKKO KOGYO CO LTD +1
View PDF22 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The thiadiazoline derivatives demonstrate antitumor activity with potential to reduce side effects and overcome drug resistance, offering a therapeutic option for a range of cancers with improved efficacy.

Problems solved by technology

These agents have side effects such as bone marrow toxicity and neuropathy, a problem of drug resistance and the like.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Thiadiazoline derivative
  • Thiadiazoline derivative
  • Thiadiazoline derivative

Examples

Experimental program
Comparison scheme
Effect test

example 1

Compound 1

[0369] Step 1: Acetophenone (4.00 g, 33.3 mmol) and thiosemicarbazide (3.15 g, 34.6 mmol) were dissolved in methanol (30 mL). To the solution was added hydrochloric acid (0.1 mL) and the mixture was vigorously stirred at room temperature for 15 hours. To the reaction mixture was added water (30 mL), and the deposited crystals were collected by filtration. The collected crystals were washed with water and diisopropyl ether, and then dried to obtain acetophenone=thiosemicarbazone (5.64 g, 88%). [0370]1H NMR (270 MHz, DMSO-d6) δ(ppm): 2.30 (S, 3H), 7.37-7.40 (m, 3H), 7.91-7.94 (m, 3H), 8.27 (br s, 1H), 10.21 (br S, 1H) [0371] Step 2: Acetophenone=thiosemicarbazone (300 mg, 0.889 mmol) obtained above was dissolved in acetic anhydride (1.0 mL, 11 mmol). After being refluxing under heating, the solution was cooled to room temperature with vigorous stirring. To the reaction mixture was added diisopropyl ether (3 mL), and the deposited crystals were collected by filtration. After...

example 2

Compound 2

[0373] Step 1: In a manner similar to that in Step 1 of Example 1, propiophenone=thiosemicarbazone (759 mg, 88%) was obtained from propiophenone (541 mg, 3.92 mmol) and thiosemicarbazide (382 mg, 4.18 mmol). [0374]1H NMR (270 MHz, DMSO-d6) δ(ppm): 1.01 (t, J=7.4 Hz, 3H), 2.85 (br q, J=7.4 Hz, 2H), 7.39 (m, 3H), 7.89 (m, 3H), 8.24 (br s, 1H), 10.30 (br s, 1H) [0375] Step 2: In a manner similar to that in Step 2 of Example 1, Compound 2 (601 mg, 76%) was obtained from propiophenone=thiosemicarbazone (559 mg, 2.70 mmol) obtained above. [0376]1H NMR (270 MHz, DMSO-d6) δ(ppm): 1.02 (t, J=7.1 Hz, 3H), 2.00 (s, 3H), 2.21 (s, 3H), 2.38 (dt, J=7.1, 7.3 Hz, 1H), 2.85 (dt, J=7.1, 7.3 Hz, 1H), 7.23-7.38 (m, 5H), 11.59 (br s, 1H)

example 3

Compound 3

[0377] Step 1: In a manner similar to that in Step 1 of Example 1, n-butyl(phenyl)methanone=thiosemicarbazone (589 mg, 63%) was obtained from n-butyl(phenyl)methanone (649 mg, 4.00 mmol) and thiosemicarbazide (367 mg, 4.03 mmol). [0378]1H NMR (270 MHz, DMSO-d6) δ(ppm): 0.99 (t, J=7.3 Hz, 3H), 1.38-1.49 (m, 4H), 2.96-2.99 (m, 2H), 7.37-7.39 (m, 3H), 7.87-7.91 (m, 3H), 8.26 (br s, 1H), 10.36 (br s, 1H) [0379] Step 2: In a manner similar to that in Step 2 of Example 1, Compound 3 (168 mg, 62%) was obtained from n-butyl(phenyl)methanone=thiosemicarbazone (200 mg, 0.850 mmol) obtained above. [0380]1H NMR (270 MHz, CDCL3) δ(ppm): 0.96 (t, J=7.3 Hz, 3H), 1.25-1.34 (m, 1H), 1.36-1.54 (m, 2H), 1.68-1.80 (m, 1H), 2.18 (s, 3H), 2.20-2.26 (m, 1H), 2.26 (s, 3H), 2.99-3.10 (m, 1H), 7.22-7.40 (m, 5H), 8.22 (br s, 1H)

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

(wherein R1 and R4 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkynyl, substituted or unsubstituted lower alkenyl, or the like; R5 represents a substituted or unsubstituted heterocyclic group, substituted or unsubstituted aryl, or the like; R2 represents —C(═W)R6 or the like; R3 represents a hydrogen atom, —C(═WA)R6A, or the like) Antitumor agents which comprises a thiadiazoline derivative represented by the aforementioned general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient are provided.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application is a divisional of application Ser. No. 10 / 497,531, which is a National Stage Application of International Application No. PCT / JP02 / 12961, filed Dec. 11, 2002, which was not published in English under PCT Article 21(2), entering the National Stage on Jun. 10, 2004, and which claims priority of Japanese Application Nos. 2001-377456, filed Dec. 11, 2001 and 2002-237399, filed Aug. 16, 2002. The entire disclosure of application Ser. No. 10 / 497,531 is considered as being part of this application, and the entire disclosure of application Ser. No. 10 / 497,531 is expressly incorporated by reference herein in its entirety.TECHNICAL FIELD [0002] The present invention relates to an antitumor agent comprising a thiadiazoline derivative or a pharmacologically acceptable salt thereof as an active ingredient, and a thiadiazoline derivative or a pharmacologically acceptable salt thereof which is useful for therapeutic treatment of a tu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): A61K31/433C07D285/135A61K31/4439A61K31/497A61K31/5377A61P35/00C07D285/12
CPCA61K31/433A61K31/4439C07D285/135A61K31/5377A61K31/497A61P35/00A61P43/00A61P7/00C07D285/12
InventorMURAKATA, CHIKARAKATO, KAZUHIKOOHTA, YOSHIHISANAKAI, RYUICHIROYAMASHITA, YOSHINORITAKAHASHI, TAKESHINAKANO, TOMOHISAINO, YOJI
OwnerKYOWA HAKKO KOGYO CO LTD